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eat shock proteins (hsps) are among the most
abundant proteins in nature and are highly
conserved amongst both eucaryotes and procary-
otes. The heat shock response is an important sur-
vival mechanism that safeguards the cell or mi-
crobe from conditions of stress. The response is
triggered transcriptionally and results in the pro-
duction of newly synthesized proteins within min-
utes of the cell or microbe encountering a stressful
environment. Little is known about the specific
functions of these hsps, but it is speculated that
they may be involved in vital cell functions, such as
the assembly and disassembly of macromolecules
and intracellular transport, as well as the proteolysis
of aberrant or dysfunctional molecules, thus main-
taining the cell in a healthy vegetative state. They
may also have a role in intracellular antigen pre-
sentation and processing,e Some hsps are constitu-
tively expressed throughout normal cycles of
growth and development, while others are induced
under hostile conditions or conditions of stress,
such as a change in temperature, pH, oxidative
state, conditions of iron or nutrient deprivation, or
the presence of enzymes or toxic chemicals.
HEAT SHOCK PROTEINS IN
INFECTIOUS DISEASES
Microbes exist in environments that are constantly
changing and have evolved mechanisms such as
the heat shock response to bring about rapid adap-
tation to environmental changes. The invasion of
microbes into a human host creates a stressful con-
dition in the host, as well as a hostile environment
for the microbes, as the host mounts an immune
response against the presence of a foreign body.
Thus an upregulation of the heat shock response
frequently occurs in both the pathogen and the
host in infectious disease. As hsps are highly con-
served in nature, it might be expected that a mam-
malian host would have innate immune tolerance
to bacterial hsps, and yet bacterial hsps are among
the most highly immunogenic targets for humans.
The underlying reason for his is still unclear, and
it is speculated that this may have an immune sur-
veillance function in that the immune response to
non-self hsp may bring about a rapid protective
immune response, perhaps through the scavenging
and regulatory function of gamma-delta T cells, the
major lymphocyte type found in the host epithe-
lium. e,3 To protect the host from destructive im-
mune responses against self-structures, autoreac-
tive T cells undergo clonal deletion in the thymus
early in life, and this self recognition is maintained
in the periphery through various regulatory sys-
tems. Yet, this system of recognition can some-
times break down, resulting in tissue damage
through autoimmune responses. There is some evi-
dence that activation of self-hsp reactive T cells
occurs during inflammatory response to infection.
CD4 and CD8 T cells with epitope specificity for
regions of high homology between microbial and
human hsps have been identified in patients with
*Correspondence to: Rosanna W. Peeling, PhD, National Laboratory for Sexually Transmited Diseases, Laboratory Centre
for Disease Control, 1015 Arlington St., Winnipeg, Manitoba, Canada.
HEAT SHOCK PROTEINS AND CHLAMYDIA INFECTION PEELING AND 31ABEY
diseases such as tuberculosis and leprosy and para-
sitic diseases such as malaria and onchocerciasis.
Thus the delicate balance between a protective
immune response against infection and an im-
mune-mediated pathogenic process may represent
an interplay between host and pathogen survival
mechanisms.
HEAT SHOCK PROTEINS IN
CHLAMYDIAL INFECTIONS
For chlamydia species, experimental work using
the mouse pneumonitis strain of Chlamydia tracho-
matis showed that the heat shock response was in-
ducible within a few minutes of placing cultures at
42-45C and that it was regulated at the level of
transcription.4 The genes encoding the 10, 60 and
70 kD hsps have been cloned and sequenced and
found to be the respective homologs of the Esch-
erichia coli groES, groEL, and dnaK genes,s-8 These
chlamydial genes arc constitutively expressed
throughout the chlamydial life cycle, and their up-
regulation during heat stress requires de novo pro-
tein synthesis. The groEL and groES genes in chla-
mydia form an operon with polycistronic messen-
ger RNA transcripts. Data from the chlamydia
genome sequencing project showed that there are
three copies of the groEL gone, but it is not clear
whether they are all expressed during the chlamyd-
ia life cycle. Expression of the dnaK gene is in-
creased at least 10-fold within 10 minutes of expo-
sure to heat shock, and the transcripts have a half-
life of approximately 5 minutes.4 All three hsps can
be found in the outer membrane complexes of el-
ementary and reticulate bodies and are extractable
with dithiothreitol or sarkosyl.9 These hsps are
highly conserved within chlamydia species, exhib-
iting greater than 95% identity at the protein level.
Of importance to the immunobiology of chla-
mydiac is that these hsps share approximately 60%
amino-acid identity with their homologs in other
bacterial species and approximately 50% homology
with the human hsps.
The DnaK (hsp70) family of proteins arc
thought to be involved in the binding, folding, and
translocation of polypeptides in intracellular trans-
port.e The function of the hsp70 in chlamydiae is
unknown, but it has been shown that it may have a
ligand function, as recombinant hsp70 expressed
on the surface of E. coli causes the bacteria to bind
to human endomctrial epithelial cells.1 It is there-
fore of interest that antibody to this protein was
shown to neutralize chlamydia infectivity in vitro. 7
The GroEL and GroES (hspl0 and hsp60) fam-
ily of hsps are thought to function as chaperones for
newly synthesized oligomeric peptides and have a
role in folding and translocation, but the precise
role of the chlamydial hsp60 (chsp60) is unknown.
Chlamydial hsp60 has been shown to be expressed
through the life cycle of chlamydiae, and it is spec-
ulated that it may be involved in the reorganization
of elementary bodies to reticulate bodies or in the
maintenance of the major outer membrane protein
in its monomeric structure in the reticulate body.6
Serum antibodies to chsp60 have been shown to
be associated with the development of adverse se-
quelae of blinding trachoma, pelvic inflammatory
disease (PID), ectopic pregnancy and tubal infer-
tility following ocular and genital C. trachomatis in-
fections.9 The first evidence for this association
came from a study of 13 infertile women, of whom
11 (85%) had an immunoglobulin (Ig) G antibody
response to a 57-kD chlamydial protein by immu-
noblot, compared with one of 11 (9%) healthy preg-
nant women with a past history of genital chlamyd-
ial infection. 1 It was later shown by cloning and
sequence analyses that the 57-kD protein belongs
to the GroEL family and that this protein can elicit,
in animal models, inflammation and histopatholog-
ic damage in infected tissue consistent with the
delayed hypersensitivity response seen in human
chlamydial disease. z
ANIMAL STUDIES
Since the demonstration that hsp60 can elicit ocu-
lar hypersensitivity, animal models of chlamydial
disease continue to provide unique opportunities
to determine the role of chsp60 in the pathogenesis
of chlamydial disease. Recombinant chlamydia
hsp70 did not cause inflammation in a primate
model of trachoma, but recombinant chsp60 elic-
ited an intense inflammatory response consistent
with the immunopathology observed in humans
with long-term complications of chlamydial dis-
ease. 13 Delayed type hypersensitivity characterized
by mononuclear infiltrates was induced in a mon-
key model ofsalpingitis when recombinant chsp60
was injected into subcutaneous pockets containing
salpingeal autotransplants of sensitized monkeys
but not in naive monkeys.4 In studies with a pri-
mate model of chronic PID, it was shown that there
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was a heterogeneity in chsp60 antibody responsive-
ness among primates experimentally infected with
C. trachomatis, a5 There were three patterns of
chsp60 antibody response: nonresponders, tran-
sient responders, and persistent responders. Simi-
larly, heterogeneity in disease outcome following
genital chlamydial infection has been observed in
humans, since only a subset of infected women
develop long-term sequelae of salpingitis, ectopic
pregnancy, or tubal infertility. In this primate
model, only a prolonged or persistent chsp60 anti-
body response correlated with persistent chlamyd-
ial infection in the fallopian tubes. Monkeys with
C. trachomatis in their fallopian tubes were more
likely to have an intense chsp60 antibody response
that persisted longer. Among the chsp60 respond-
ers, a more intense chsp60 response correlated with
a more severe gross pathology before treatment.
Compared with the serologic response using the
microimmunofluorescence (MIF) assay, the chsp60
antibody response appeared to be a more specific
marker for chlamydial tubal infection. The similar-
ity of disease outcome observed in this animal
model with that in human studies makes this a
useful model for further work on the role of chsp60
in the pathogenesis of chlamydial disease and may
yield clues to the prevention of chlamydia-
associated tubal infertility.
ASSOCIATION OF SEROLOGIC RESPONSES
TO CHLAMYDIAL HEAT SHOCK PROTEIN
60 WITH ADVERSE OUTCOMES IN THE EYE
AND GENITAL TRACT
Toye et al. developed an enzyme immunoassay us-
ing purified recombinant chsp60 as antigen and
confirmed that serum antibody to chsp60 was
strongly associated with the development of tubal
infertility in women seropositive for C. trachoma-
tis. a6 Several other studies since then have demon-
strated the relationship between the prevalence of
serum IgG antibody response to chsp60 and the
progressive development of adverse reproductive
sequelae in women (Fig. 1). 11’16’17-22 Dieterle ct al.
showed that there was no significant difference in
serum IgG antibodies to both chsp60 and chsp70 in
women with chlamydia-associated chronic salpin-
gitis and/or tubal occlusion when compared with
those with no evidence of tubal occlusion,z3 How-
ever, the presence of serum IgA antibody re-
sponses to chsp60 was correlated with chlamydia-
100
A
fertile cervicitis PID tubal
occlusion
Fig. I. The prevalence of chsp60 antibody in women with
a past history of genital chlamydial infection who are fertile,
who have acute cervicitis or PID, or who have been diag-
nosed with ectopic pregnancy or tubal infertility as a result
of tubal occlusion. Data drawn from references II (o),16
(*), 17 (&), 18 (1), 19 (X), 20 (), 21(+).
associated chronic salpingitis and/or tubal occlu-
sion.
Two studies examined this association prospec-
tively. In a study of 280 women with a history of
genital chlamydia infection, the presence of serum
IgG antibodies to chsp60 was predictive of the de-
velopment of PID, with an odds ratio of 2.12.z4 In
men, serum antibody to chsp60 was not associated
with acute urethritis but was associated with the
development of chronic urethritis on follow-up at
10-92 days after diagnosis and treatment of urethri-
tis. z5 Of 43 men who showed signs of inflammation
in their urethral smear on follow up and were se-
ropositive for C. trachomatis, 23 had detectable se-
rum chsp60 antibodies. Twenty of these 23 pa-
tients (87%) developed chronic urethritis, com-
pared with 11/20 (55%) who had no chsp60
antibodies (P < .05).
In ocular chlamydial infection, the presence of
serum IgG antibodies was associated with the de-
velopment of conjunctival scarring in a case-control
study of 296 children and adults from a trachoma
endemic area of Gambia.z6 Of interest, the preva-
lence of chsp60 antibody in the cases of trachoma-
tous scarring was only 32%, compared with ap-
proximately 80% in women with chlamydia-
associated tubal occlusion, as shown in Figure 1.
The reason for this is not clear. It may reflect the
smaller area of epithelium infected. Alternatively,
it is possible that other factors, such as recurrent
cycles of bacterial infection, may contribute to the
progression of conjunctival scarring in trachoma.
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TABLE I. Summary of antibody response to chsp60 fragments or by peptide mapping in women with various
consequences of genital chlamydial infection
Peptide reactivity (no. reacted/no, tested)
Study Peptides PID Infertility Fertile Controls
Cerrone et al. 1-51 0/8 Not done Not done
50-143 0/8
50-266 0/8
274-402 4/8 (50%)
405-544 5/8 (63%)
Arno et al.22 2-544 Not done I/21 (5%) 0/9
101-544 1/21 (5%) 0/9
201-544 1/21 (52%) 0/9
301-544 0/21 0/9
401-544 1/21 (52%) I/9 (I I%)
Domeika et al.32 15 I-I 62 41/129 (32%) Not done
260-271 51/129 (40%)
Witkin et al.33 260-271 2/17 (12%) 2/8 (25%) 0/3
8/13 (62%)
2/7 (29%)
aNumbers denote positions in the amino acid sequence.
bCases for Cerrone et al. are women with PID; for A’rfio et al., women with tubal infertility; for Domeika et al., women with PID; and for Witkin et
al., women with spontaneous abortion.
Does antibody response to chsp60 have any ef-
fect on the success of in vitro fertilization? The
answer is equivocal. Witkin showed that the pres-
ence of IgA antibody at the cervix was associated
with a poor outcome of in vitro fertilization,z7,z8
Cervical chsp60 IgA was detected in 36 (28%) of
130 women with unsuccessful embryo transfers,
three (30%) of 10 women with spontaneous abor-
tions, seven (33%) of 21 women with biochemical
pregnancies, five (33%) of 15 women whose oo-
cytes failed to become fertilized, and 26 (26%) of
99 women who did not become pregnant, com-
pared with five (7%) of 68 women who had suc-
cessful term births. Claman showed that in vitro
fertilization was more successful in women with
serum IgG antibody response to chsp60,z9 It has
been speculated that cell-mediated immunity is
depressed in pregnancy to lower the risk of rejec-
tion of the fetus, and thus pregnant women may
have a predominantly TH2 response to infection.
Although it remains unclear how the presence of
cervical or serum chsp60 antibody may have an
effect on fertilization outcome, Witkin et al. spec-
ulated that asymptomatic chlamydial infection or
reactivation of the hsp60 response may induce an
inflammatory reaction in the uterus which in turn
impairs and/or rejects embryo transplant,zs
Is the intensity of the chsp60 response corre-
lated with the severity of the outcome? In a pro-
spective study of 157 women with a clinical diag-
nosis of PID, 73 women had laparoscopically con-
firmed salpingitis and were assessed for perihep-
atitis.3 A chsp60 antibody absorbance reading of
0.5 or greater was detected in 12 of 18 (67%)
women with laparoscopically confirmed perihepa-
titis, compared with 12 of 43 (28%) in the salpin-
gitis only group (P .005). The mean chsp60 an-
tibody absorbance was also significantly higher in
the perihepatitis group (P .02). Perihepatitis cor-
related with moderate to severe pelvic adhesions
but not with peritoneal pus, suggesting a more in-
tense inflammatory response in these patients than
in women with salping;itis alone. In a study of hu-
man PID, the highest chsp60 titers were found in
80% of women who had occluded tubes. 17 The
strong association of chsp60 antibody and tubal oc-
clusion was independent of MIF IgG antibody as
shown in other studies. 16
Several studies attempted to identify the immu-
nodominant regions of the protein and correlate
these regions with potential homology and hence
cross-reactivity to the human hsp60. The results
arc not conclusive (Table 1). Cerrone et al. cloned
the entire chsp60 from C. trachomatis serovar L2 as
well as fragments of the protein and found that
among eight women with chlamydial PID, four re-
acted to the fragment that consisted of amino acids
274-402, and five reacted to the fragments with
amino acids 405-544.6 The amino terminal of the
chsp60 did not appear to be immunogenic in their
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study. Although this was confirmed by Arno’s
study also using cloned fragments, studies using
synthetic peptides showed that there are many im-
munoreactive regions, including the amino termi-
nal, each of which have the potential to cause cross-
reactivity with the human hsp.ze,31,3e Amino acids
260-271 were identified as an immunodominant
peptide conserved between human and chlamydial
hsp60.3
ASSOCIATION OF CELL-MEDIATED
IMMUNITY TO CHLAMYDIAL HEAT SHOCK
PROTEIN 60 WITH DISEASE OUTCOME
Holland et al. found that subjects with trachoma-
tous scarring had weaker cell-mediated immune re-
sponses, in terms of lymphocyte proliferation and
interferon-gamma production, to chsp60 and other
chlamydial antigens than age- and sex-matched
controls from endemic communities.4 Moreover,
subjects who spontaneously cleared ocular chla-
mydial infection had stronger lymphoproliferative
responses to chsp60, the major outer membrane
protein, and whole organisms than those with per-
sistent infection. "s Studies in knockout mice
showed that cell-mediated immunity is important
in clearance of infection.36 Thus, subjects with tra-
chomatous scarring may have a predominantly
TH2 response to chlamydial antigens, impairing
their ability to clear the infection. Previous studies
have shown that women with tubal infertility had
higher levels of chlamydial antibody than fertile
controls, consistent with the hypothesis that these
women had a predominantly TH2 response to chla-
mydial infection. 1,16,37 Witkin et al. showed that
women with laparoscopically verified salpingitis
were more likely to have a lymphoproliferative re-
sponse to chsp60 than women who had cervicitis or
recurrent abortions.38 These responses were shown
to be stimulated by various epitopes, some of
which are conserved between human and chlamyd-
ial hsp60.39
GENETIC RESTRICTION OF I.MMUNE
RESPONSES TO CHLAMYDIAL HEAT
SHOCK PROTEIN 60 IN
CHLAMYDIAL INFECTION
The heterogeneity in chlamydial disease outcome
suggests that there may be a genetic susceptibility
to long-term complications of chlamydial disease.
It is speculated that this genetic restriction may be
linked to the control of immune response genes.
Genetic restriction in immune responses to chsp60
may partially explain the heterogeneity in disease
outcome following genital chlamydial infection. In
a mouse model, it was shown that antibody re-
sponse to the chlamydial hsp60 and hspT0 are
tightly controlled by genes in the H-2 locus and
that the trait for high antibody response to hsps was
dominant.4 It is estimated that only a third of
women with cervical infection develop PID, of
whom one third will progress to tubal occlusion.7
The development of PID has been shown to cor-
relate with the human leukocyte antigen A-31 al-
lele, but this is not correlated with the chsp60 an-
tibody response. 18
In studies of trachomatous scarring in trachoma
endemic communities in Gambia, chsp60 antibody
response was positively correlated with human leu-
kocyte antigen class-II allele DRI310701 and
negatively correlated with DQI310301 and
DQ[I*0501.26’4 However, as none of these alleles
were directly correlated with evidence of disease,
susceptibility to disease due to the genetic regula-
tion of host immune response may be complex.
Although other host or microbial determinants
likely contribute to the development of immuno-
pathology following genital chlamydial infection,
the data reviewed thus far suggest that through
genetic control of their immune response, some
individuals with chlamydial infection appear to be
unable to clear their infection, resulting in a per-
sistently infected state in which the host and
pathogen achieve a delicate balance as previously
described. In turn, this may lead to the increased
expression of both host and chlamydial chsp60.
From this point, several possibilities for immune-
mediated damage exist, which arc not by any
means mutually exclusive.
POSSIBLE MECHANISMS OF PATHOGENESIS
The origin of continued antigenic stimulation to
sustain the antibody response to chsp60 in the ab-
sence of clinically inapparent infection remain un-
defined. Beatty et al. showed that in cell cultures
persistently infected with C. trachomatis the expres-
sion of hsp60 is maintained at normal levels, while
other proteins, such as the major outer membrane
protein, are downregulated.4e This has led to the
suggestion that the chsp60 antibody response is
either a marker of persistent chlamydial infection
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or is somehow causally related to the development
of immunopathology in chlamydial disease,, per-
haps through an autoimmune response. It is also
possible that chsp60 or other chlamydial antigens
may be involved in immune complexes that cause
inflammation in the infected tissues.43 These
mechanisms may not be mutually exclusive.
Autoimmunity
Since hsps are highly conserved, antibody response
to chsp60 may be a marker of autoimmune re-
sponses initiated by cross-reactivity between
chsp60 and host cell hsp60 epitopcs. The induction
of autoimmune responses as a result of molecular
mimicry between bacterial hsp and human hsp has
been documented,e Lin et al. showed that the in-
duction of autoreactive B cells by simultaneous in-
jection of a self and a heterologous protein allows
the priming of autoreactive T cells.44 In a mouse
model, tolerance to mouse hsp60 was broken by
the simultaneous injection of mouse and chlamyd-
ial hsp60.4s Although immunogenic epitopes that
are cross-reactive between chlamydial and human
hsp60 have been identified in a number of studies
as previously described, the activation of autoreac-
tive T cells is a complex process, and high homol-
ogy between bacterial and human proteins may not
necessarily lead to cross-reactivity. Other host de-
terminants, such as the ability of peptides to bind
to major histocompatibility complex molecules, are
also important in the process. Given the frequency
with which humans encounter microbial patho-
gens, the highly conserved nature of hsp, and the
fact that antibodies and T cells with specificity for
cross-reactive epitopes between microbial and hu-
man hsp have been found in healthy individuals, it
is unlikely that hsps are the primary inducers of
autoimmune responses in infection,z However, it is
possible that hsps may have a role in priming self-
hsp reactive T cells or in exacerbating an ongoing
autoimmune process.
The Role of Chlamydial Heat Shock Protein 60
as a Marker for Persistent Infection
Evidence for persistent chlamydial infection has
been described.46 C. trachomatis DNA and antigen
have been found in the fallopian tubes of women
with postinfectious tubal infertility, presumably as
a result of a persistent chlamydial infection in the
fallopian tubes.47 In a study of human PID, MIF
IgA response in serum is significantly correlated
with the finding of chsp60 IgG response in women
with confirmed PID but not among women with
acute chlamydial infection. Since serum IgA has a
short half-life, the data suggest that these women
may be harboring a persistent chlamydial infection.
Repeated cervical chlamydial infection has been
identified as a risk factor for human PID, as well as
for tubal obstruction in a monkey model of salpin-
gitis. 18,48 Thus, chsp60 antibody response may be
useful to identify individuals at risk of long-term
complications of chlamydial disease.49
Other alternative but not mutually exclusive hy-
potheses for the role of chsp60 in immunopathol-
ogy include, first, that the chsp60 antibody re-
sponse is part of a highly polarized T cell response
that causes tissue fibrosis as seen in schistosomia-
sis.s T-cell responses to chsp60 may mediate the
inflammatory pathology associated with ocular and
genital chlamydial infection. Studies from tra-
choma endemic areas showed that individuals with
scarring trachoma have depressed T-cell responses
to chlamydial antigens, including chsp60, com-
pared with individuals who were able to resolve
their chlamydial infections, suggesting that a pre-
dominantly TH2 response fails to clear chlamydial
infection.34,3s
It may be possible to distinguish the underlying
mechanism of autoimmunity or persistent infection
through studies of antimicrobial treatment. If per-
sistent chlamydial infection, characterized by anti-
body response to chsp60, was the cause of immu-
nopathology in acute chlamydial PID, then antimi-
crobial treatment that eradicates the infection
should be effective in modulating the antibody re-
sponse and the subsequent development of tubal
pathology. On the other hand, if chsp60 itself is the
cause of inflammation in the absence of an active
infection, possibly because of an autoimmune re-
sponse to the human hsp60, then the effect of
treatment on chsp60 antibody response and immu-
nopathology would be limited.
CONCLUSION
Heat shock proteins are expressed constitutively
throughout the life cycle of chlamydiae, as well as
under conditions of stress. Antibody to chsp70 is
associated with protective immunity in vitro, while
antibody to the chsp60 is associated with the de-
velopment of immunopathology in chlamydial in-
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fection, leading to blinding trachoma, PID, ectopic
pregnancy, and tubal infertility. There is evidence
to suggest that the chsp60 antibody response may
be useful as a marker of persistent infection in the
fallopian tubes and therefore may be useful to
identify women at risk of developing tubal pathol-
ogy. In such women, it may be possible to initiate
intervention, such as more aggressive antimicrobial
treatment, before tubal occlusion occurs. The effi-
cacy of antimicrobial regimens presently recom-
mended for the treatment of human PID is largely
based on the resolution of symptoms. Whether the
organism is actually eradicated from the fallopian
tubes, hence preserving fertility, is uncertain. Fur-
ther studies are required to determine whether this
response may be useful to monitor treatment effi-
cacy in human PID. The role of chsp60 in the
development of immunopathology r.emains un-
clear. Studies are needed to determine whether
chsp60 is the inducing or exacerbating antigen at
the site of inflammation, how chsp molecules are
presented to and processed by the host immune
system, and how that may result in the different
outcome of protective and damaging immune re-
sponses observed in chlamydial infection. This
knowledge will be important to further our under-
standing of chlamydial disease and may offer op-
portunities for disease control and prevention.
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